KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) EBIT (2016 - 2025)

Historic EBIT for Johnson & Johnson (JNJ) over the last 17 years, with Q3 2025 value amounting to $7.0 billion.

  • Johnson & Johnson's EBIT rose 3962.68% to $7.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $23.5 billion, marking a year-over-year increase of 827.53%. This contributed to the annual value of $21.0 billion for FY2024, which is 234.67% down from last year.
  • Johnson & Johnson's EBIT amounted to $7.0 billion in Q3 2025, which was up 3962.68% from $6.6 billion recorded in Q2 2025.
  • Johnson & Johnson's EBIT's 5-year high stood at $7.0 billion during Q3 2025, with a 5-year trough of $3.6 billion in Q4 2024.
  • Moreover, its 5-year median value for EBIT was $5.8 billion (2023), whereas its average is $5.6 billion.
  • Per our database at Business Quant, Johnson & Johnson's EBIT skyrocketed by 5520.52% in 2021 and then plummeted by 3809.52% in 2023.
  • Johnson & Johnson's EBIT (Quarter) stood at $6.6 billion in 2021, then decreased by 19.79% to $5.3 billion in 2022, then dropped by 19.78% to $4.3 billion in 2023, then dropped by 15.34% to $3.6 billion in 2024, then soared by 95.42% to $7.0 billion in 2025.
  • Its last three reported values are $7.0 billion in Q3 2025, $6.6 billion for Q2 2025, and $6.2 billion during Q1 2025.